1 Ahlmann M, Hempel G (2016) The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy. Cancer Chemother Pharmacol 78: 661-671 Doi 10.1007/s00280-016-3152-1
2 Altmann A, Tian L, Henderson VW, Greicius MD, Alzheimer's Disease Neuroimaging Initiative I (2014) Sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol 75: 563-573 Doi 10.1002/ana.24135
3 Arranz L, De Castro NM, Baeza I, Gimenez-Llort L, De la Fuente M (2011) Effect of environmental enrichment on the immunoendocrine aging of male and female triple-transgenic 3xTg-AD mice for Alzheimer's disease. J Alzheimers Dis 25: 727-737 Doi 10.3233/JAD-2011-110236
4 Arsenault D, Dal-Pan A, Tremblay C, Bennett DA, Guitton MJ, De Koninck Y, Tonegawa S, Calon F (2013) PAK inactivation impairs social recognition in 3xTg-AD Mice without increasing brain deposition of tau and Abeta. J Neurosci 33: 10729-10740 Doi 10.1523/JNEUROSCI.1501-13.2013
5 Association As (2019) 2019 Alzheimer's disease facts and figures. Alzheimer's & Dementia 15: 321-387 Doi 10.1016/j.jalz.2019.01.010
6 Bakeman R (2005) Recommended effect size statistics for repeated measures designs. Behav Res Methods 37: 379-384 Doi 10.3758/bf03192707
7 Balcombe JP, Barnard ND, Sandusky C (2004) Laboratory routines cause animal stress. Journal of the American Association for Laboratory Animal Science 43: 42-51
8 Bartos A, Fialova L, Svarcova J (2018) Lower Serum Antibodies Against Tau Protein and Heavy Neurofilament in Alzheimer's Disease. J Alzheimers Dis 64: 751-760 Doi 10.3233/jad-180039
9 Baruch K, Rosenzweig N, Kertser A, Deczkowska A, Sharif AM, Spinrad A, Tsitsou-Kampeli A, Sarel A, Cahalon L, Schwartz M (2015) Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology. Nat Commun 6: 7967 Doi 10.1038/ncomms8967
10 Belfiore R, Rodin A, Ferreira E, Velazquez R, Branca C, Caccamo A, Oddo S (2019) Temporal and regional progression of Alzheimer's disease-like pathology in 3xTg-AD mice. Aging Cell 18: e12873 Doi 10.1111/acel.12873
11 Berti V, Mosconi L, Glodzik L, Li Y, Murray J, De Santi S, Pupi A, Tsui W, De Leon MJ (2011) Structural brain changes in normal individuals with a maternal history of Alzheimer's. Neurobiol Aging 32: 2325 e2317-2326 Doi 10.1016/j.neurobiolaging.2011.01.001
12 Bilkei-Gorzo A (2014) Genetic mouse models of brain ageing and Alzheimer's disease. Pharmacol Ther 142: 244-257 Doi 10.1016/j.pharmthera.2013.12.009
13 Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM (2005) Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45: 675-688 Doi 10.1016/j.neuron.2005.01.040
14 Blazquez G, Canete T, Tobena A, Gimenez-Llort L, Fernandez-Teruel A (2014) Cognitive and emotional profiles of aged Alzheimer's disease (3xTgAD) mice: effects of environmental enrichment and sexual dimorphism. Behav Brain Res 268: 185-201 Doi 10.1016/j.bbr.2014.04.008
15 Bories C, Guitton MJ, Julien C, Tremblay C, Vandal M, Msaid M, De Koninck Y, Calon F (2012) Sex-dependent alterations in social behaviour and cortical synaptic activity coincide at different ages in a model of Alzheimer's disease. PLoS One 7: e46111 Doi 10.1371/journal.pone.0046111
16 Brodsky RA (2010) High-dose cyclophosphamide for autoimmunity and alloimmunity. Immunol Res 47: 179-184 Doi 10.1007/s12026-009-8149-y
17 Bryniarski K, Szczepanik M, Ptak M, Zemelka M, Ptak W (2009) Influence of cyclophosphamide and its metabolic products on the activity of peritoneal macrophages in mice. Pharmacol Rep 61: 550-557 Doi 10.1016/s1734-1140(09)70098-2
18 Bygrave AE, Rose KL, Cortes-Hernandez J, Warren J, Rigby RJ, Cook HT, Walport MJ, Vyse TJ, Botto M (2004) Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol 2: E243 Doi 10.1371/journal.pbio.0020243
19 Canete T, Blazquez G, Tobena A, Gimenez-Llort L, Fernandez-Teruel A (2015) Cognitive and emotional alterations in young Alzheimer's disease (3xTgAD) mice: effects of neonatal handling stimulation and sexual dimorphism. Behav Brain Res 281: 156-171 Doi 10.1016/j.bbr.2014.11.004
20 Carlucci F, Cortes-Hernandez J, Fossati-Jimack L, Bygrave AE, Walport MJ, Vyse TJ, Cook HT, Botto M (2007) Genetic dissection of spontaneous autoimmunity driven by 129-derived chromosome 1 Loci when expressed on C57BL/6 mice. J Immunol 178: 2352-2360 Doi 10.4049/jimmunol.178.4.2352
21 Carroll JC, Rosario ER, Kreimer S, Villamagna A, Gentzschein E, Stanczyk FZ, Pike CJ (2010) Sex differences in beta-amyloid accumulation in 3xTg-AD mice: role of neonatal sex steroid hormone exposure. Brain Res 1366: 233-245 Doi 10.1016/j.brainres.2010.10.009
22 Chan EKL, Damoiseaux J, Carballo OG, Conrad K, de Melo Cruvinel W, Francescantonio PLC, Fritzler MJ, Garcia-De La Torre I, Herold M, Mimori Tet al (2015) Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014-2015. Front Immunol 6: 412-412 Doi 10.3389/fimmu.2015.00412
23 Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, Siao CJ, Herrera DG, Toth M, Yang C, McEwen BSet al (2006) Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314: 140-143 Doi 10.1126/science.1129663
24 Chene G, Beiser A, Au R, Preis SR, Wolf PA, Dufouil C, Seshadri S (2015) Gender and incidence of dementia in the Framingham Heart Study from mid-adult life. Alzheimer's & dementia : the journal of the Alzheimer's Association 11: 310-320 Doi 10.1016/j.jalz.2013.10.005
25 Cho SM, Lee S, Yang SH, Kim HY, Lee MJ, Kim HV, Kim J, Baek S, Yun J, Kim Det al (2016) Age-dependent inverse correlations in CSF and plasma amyloid-beta(1-42) concentrations prior to amyloid plaque deposition in the brain of 3xTg-AD mice. Sci Rep 6: 20185 Doi 10.1038/srep20185
26 Clinton LK, Billings LM, Green KN, Caccamo A, Ngo J, Oddo S, McGaugh JL, LaFerla FM (2007) Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice. Neurobiol Dis 28: 76-82 Doi 10.1016/j.nbd.2007.06.013
27 Cohen J (2013) Statistical power analysis for the behavioral sciences. Academic press, City
28 Denenberg VH, Mobraaten LE, Sherman GF, Morrison L, Schrott LM, Waters NS, Rosen GD, Behan PO, Galaburda AM (1991) Effects of the autoimmune uterine/maternal environment upon cortical ectopias, behavior and autoimmunity. Brain Res 563: 114-122 Doi 10.1016/0006-8993(91)91522-3
29 Di Benedetto G, Burgaletto C, Carta AR, Saccone S, Lempereur L, Mulas G, Loreto C, Bernardini R, Cantarella G (2019) Beneficial effects of curtailing immune susceptibility in an Alzheimer's disease model. J Neuroinflammation 16: 166 Doi 10.1186/s12974-019-1554-9
30 Di Meco A, Joshi YB, Lauretti E, Pratico D (2016) Maternal dexamethasone exposure ameliorates cognition and tau pathology in the offspring of triple transgenic AD mice. Mol Psychiatry 21: 403-410 Doi 10.1038/mp.2015.78
31 Ehrlich ME, Gandy S (2011) Chromatin plasticity and the pathogenesis of Huntington disease. Proc Natl Acad Sci U S A 108: 16867-16868 Doi 10.1073/pnas.1113321108
32 Emadi A, Jones RJ, Brodsky RA (2009) Cyclophosphamide and cancer: golden anniversary. Nature reviews Clinical oncology 6: 638
33 Espana J, Gimenez-Llort L, Valero J, Minano A, Rabano A, Rodriguez-Alvarez J, LaFerla FM, Saura CA (2010) Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice. Biol Psychiatry 67: 513-521 Doi 10.1016/j.biopsych.2009.06.015
34 Fahnestock M (2011) Brain-derived neurotrophic factor: the link between amyloid-β and memory loss. Future Neurol 6: 627-639 Doi 10.2217/fnl.11.44
35 Ferreira ST, Lourenco MV, Oliveira MM, De Felice FG (2015) Soluble amyloid-beta oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease. Front Cell Neurosci 9: 191 Doi 10.3389/fncel.2015.00191
36 Ferretti MT, Iulita MF, Cavedo E, Chiesa PA, Schumacher Dimech A, Santuccione Chadha A, Baracchi F, Girouard H, Misoch S, Giacobini Eet al (2018) Sex differences in Alzheimer disease — the gateway to precision medicine. Nature Reviews Neurology 14: 457-469 Doi 10.1038/s41582-018-0032-9
37 Furr RM (2004) Interpreting Effect Sizes in Contrast Analysis. Understanding Statistics 3: 1-25 Doi 10.1207/s15328031us0301_1
38 Garcia-Mesa Y, Lopez-Ramos JC, Gimenez-Llort L, Revilla S, Guerra R, Gruart A, Laferla FM, Cristofol R, Delgado-Garcia JM, Sanfeliu C (2011) Physical exercise protects against Alzheimer's disease in 3xTg-AD mice. J Alzheimers Dis 24: 421-454 Doi 10.3233/JAD-2011-101635
39 Garzon DJ, Fahnestock M (2007) Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells. J Neurosci 27: 2628-2635 Doi 10.1523/JNEUROSCI.5053-06.2007
40 Gimenez-Llort L, Arranz L, Mate I, De la Fuente M (2008) Gender-specific neuroimmunoendocrine aging in a triple-transgenic 3xTg-AD mouse model for Alzheimer's disease and its relation with longevity. Neuroimmunomodulation 15: 331-343 Doi 10.1159/000156475
41 Gimenez-Llort L, Blazquez G, Canete T, Johansson B, Oddo S, Tobena A, LaFerla FM, Fernandez-Teruel A (2007) Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid. Neurosci Biobehav Rev 31: 125-147 Doi 10.1016/j.neubiorev.2006.07.007
42 Gimenez-Llort L, Garcia Y, Buccieri K, Revilla S, Sunol C, Cristofol R, Sanfeliu C (2010) Gender-Specific Neuroimmunoendocrine Response to Treadmill Exercise in 3xTg-AD Mice. Int J Alzheimers Dis 2010: 128354 Doi 10.4061/2010/128354
43 Gimenez-Llort L, Rivera-Hernandez G, Marin-Argany M, Sanchez-Quesada JL, Villegas S (2013) Early intervention in the 3xTg-AD mice with an amyloid beta-antibody fragment ameliorates first hallmarks of Alzheimer disease. mAbs 5: 665-677 Doi 10.4161/mabs.25424
44 Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin Set al (2013) TREM2 variants in Alzheimer's disease. N Engl J Med 368: 117-127 Doi 10.1056/NEJMoa1211851
45 Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8: 101-112 Doi 10.1038/nrm2101
46 Hirata-Fukae C, Li HF, Hoe HS, Gray AJ, Minami SS, Hamada K, Niikura T, Hua F, Tsukagoshi-Nagai H, Horikoshi-Sakuraba Yet al (2008) Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res 1216: 92-103 Doi 10.1016/j.brainres.2008.03.079
47 Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina Vet al (2011) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 43: 429-435 Doi 10.1038/ng.803
48 Honea RA, Swerdlow RH, Vidoni ED, Burns JM (2011) Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease. Neurology 76: 822-829 Doi 10.1212/WNL.0b013e31820e7b74
49 Hu Y, Chopra V, Chopra R, Locascio JJ, Liao Z, Ding H, Zheng B, Matson WR, Ferrante RJ, Rosas HDet al (2011) Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse. Proc Natl Acad Sci U S A 108: 17141-17146 Doi 10.1073/pnas.1104409108
50 Hutton CP, Lemon JA, Sakic B, Rollo CD, Boreham DR, Fahnestock M, Wojtowicz JM, Becker S (2018) Early intervention with a multi-ingredient dietary supplement improves mood and spatial memory in a triple transgenic mouse model of Alzheimer's Disease. J Alzheimers Dis 64: 835-857 Doi 10.3233/JAD-170921
51 Hyman BT, Smith C, Buldyrev I, Whelan C, Brown H, Tang MX, Mayeux R (2001) Autoantibodies to amyloid-beta and Alzheimer's disease. Ann Neurol 49: 808-810 Doi 10.1002/ana.1061
52 Inomata K, Aoto T, Binh NT, Okamoto N, Tanimura S, Wakayama T, Iseki S, Hara E, Masunaga T, Shimizu Het al (2009) Genotoxic stress abrogates renewal of melanocyte stem cells by triggering their differentiation. Cell 137: 1088-1099 Doi 10.1016/j.cell.2009.03.037
53 Isopi E, Granzotto A, Corona C, Bomba M, Ciavardelli D, Curcio M, Canzoniero LM, Navarra R, Lattanzio R, Piantelli Met al (2015) Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology. Neurobiol Dis 81: 214-224 Doi 10.1016/j.nbd.2014.11.013
54 Janelsins MC, Mastrangelo MA, Oddo S, LaFerla FM, Federoff HJ, Bowers WJ (2005) Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice. J Neuroinflammation 2: 23 Doi 10.1186/1742-2094-2-23
55 Kapadia M, Bijelic D, Zhao H, Ma D, Stojanovich L, Milosevic M, Andjus P, Sakic B (2017) Effects of sustained i.c.v. infusion of lupus CSF and autoantibodies on behavioral phenotype and neuronal calcium signaling. Acta neuropathologica communications 5: 70 Doi 10.1186/s40478-017-0473-1
56 Kapadia M, Mian MF, Michalski B, Azam AB, Ma D, Salwierz P, Christopher A, Rosa E, Zovkic IB, Forsythe Pet al (2018) Sex-dependent differences in spontaneous autoimmunity in adult 3xTg-AD mice. J Alzheimers Dis 63: 1191-1205 Doi 10.3233/JAD-170779
57 Kapadia M, Zhao H, Ma D, Hatkar R, Marchese M, Sakic B (2014) Zoopharmacognosy in diseased laboratory mice: conflicting evidence. PLoS One 9: e100684 Doi 10.1371/journal.pone.0100684
58 Kapadia M, Zhao H, Ma D, Sakic B (2017) Sustained immunosuppression alters olfactory function in the MRL model of CNS Lupus. J Neuroimmune Pharmacol 12: 555-564 Doi 10.1007/s11481-017-9745-6
59 Kawabata D, Venkatesh J, Ramanujam M, Davidson A, Grimaldi CM, Diamond B (2010) Enhanced Selection of High Affinity DNA-Reactive B Cells Following Cyclophosphamide Treatment in Mice. PLoS One 5: e8418 Doi 10.1371/journal.pone.0008418
60 Kitazawa M, Oddo S, Yamasaki TR, Green KN, LaFerla FM (2005) Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J Neurosci 25: 8843-8853 Doi 10.1523/JNEUROSCI.2868-05.2005
61 Klein SL, Flanagan KL (2016) Sex differences in immune responses. Nat Rev Immunol 16: 626-638 Doi 10.1038/nri.2016.90
62 Krestova M, Ricny J, Bartos A (2018) Changes in concentrations of tau-reactive antibodies are dependent on sex in Alzheimer's disease patients. J Neuroimmunol 322: 1-8 Doi 10.1016/j.jneuroim.2018.05.004
63 Kumar DK, Choi SH, Washicosky KJ, Eimer WA, Tucker S, Ghofrani J, Lefkowitz A, McColl G, Goldstein LE, Tanzi REet al (2016) Amyloid-beta peptide protects against microbial infection in mouse and worm models of Alzheimer's disease. Sci Transl Med 8: 340ra372 Doi 10.1126/scitranslmed.aaf1059
64 Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier Bet al (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41: 1094-1099 Doi 10.1038/ng.439
65 Laws KR, Irvine K, Gale TM (2018) Sex differences in Alzheimer's disease. Current opinion in psychiatry 31: 133-139 Doi 10.1097/YCO.0000000000000401
66 Lepack AE, Bagot RC, Pena CJ, Loh YE, Farrelly LA, Lu Y, Powell SK, Lorsch ZS, Issler O, Cates HMet al (2016) Aberrant H3.3 dynamics in NAc promote vulnerability to depressive-like behavior. Proc Natl Acad Sci U S A 113: 12562-12567 Doi 10.1073/pnas.1608270113
67 Levine S, Saltzman A, Levy E, Ginsberg SD (2009) Systemic pathology in aged mouse models of Down's syndrome and Alzheimer's disease. Exp Mol Pathol 86: 18-22 Doi 10.1016/j.yexmp.2008.10.006
68 Mah L, Binns MA, Steffens DC, Alzheimer's Disease Neuroimaging I (2015) Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease. Am J Geriatr Psychiatry 23: 466-476 Doi 10.1016/j.jagp.2014.10.005
69 Marchese M, Cowan D, Head E, Ma D, Karimi K, Ashthorpe V, Kapadia M, Zhao H, Davis P, Sakic B (2014) Autoimmune manifestations in the 3xTg-AD model of Alzheimer's disease. J Alzheimers Dis 39: 191-210 Doi 10.3233/JAD-131490
70 Maze I, Wenderski W, Noh KM, Bagot RC, Tzavaras N, Purushothaman I, Elsasser SJ, Guo Y, Ionete C, Hurd YLet al (2015) Critical role of histone turnover in neuronal transcription and plasticity. Neuron 87: 77-94 Doi 10.1016/j.neuron.2015.06.014
71 Mebius RE, Kraal G (2005) Structure and function of the spleen. Nat Rev Immunol 5: 606-616 Doi 10.1038/nri1669
72 Medeiros R, Castello NA, Cheng D, Kitazawa M, Baglietto-Vargas D, Green KN, Esbenshade TA, Bitner RS, Decker MW, LaFerla FM (2014) alpha7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles. Am J Pathol 184: 520-529 Doi 10.1016/j.ajpath.2013.10.010
73 Mehta S, Jeffrey KL (2015) Beyond receptors and signaling: epigenetic factors in the regulation of innate immunity. Immunol Cell Biol 93: 233-244 Doi 10.1038/icb.2014.101
74 Meijer MK, Spruijt BM, van Zutphen LF, Baumans V (2006) Effect of restraint and injection methods on heart rate and body temperature in mice. Lab Anim 40: 382-391 Doi 10.1258/002367706778476370
75 Michalski B, Corrada MM, Kawas CH, Fahnestock M (2015) Brain-derived neurotrophic factor and TrkB expression in the "oldest-old," the 90+ Study: correlation with cognitive status and levels of soluble amyloid-beta. Neurobiol Aging 36: 3130-3139 Doi 10.1016/j.neurobiolaging.2015.08.022
76 Moir RD, Lathe R, Tanzi RE (2018) The antimicrobial protection hypothesis of Alzheimer's disease. Alzheimer's & dementia : the journal of the Alzheimer's Association 14: 1602-1614 Doi 10.1016/j.jalz.2018.06.3040
77 Monsonego A, Nemirovsky A, Harpaz I (2013) CD4 T cells in immunity and immunotherapy of Alzheimer's disease. Immunology 139: 438-446
78 Mosconi L, Berti V, Swerdlow RH, Pupi A, Duara R, de Leon M (2010) Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes. Human genomics 4: 170-193 Doi 10.1186/1479-7364-4-3-170
79 Myung NH, Zhu X, Kruman, II, Castellani RJ, Petersen RB, Siedlak SL, Perry G, Smith MA, Lee HG (2008) Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes. Age (Dordrecht, Netherlands) 30: 209-215 Doi 10.1007/s11357-008-9050-7
80 Nabar NR, Yuan F, Lin X, Wang L, Bai G, Mayl J, Li Y, Zhou SF, Wang J, Cai Jet al (2012) Cell therapy: a safe and efficacious therapeutic treatment for Alzheimer's disease in APP+PS1 mice. PLoS One 7: e49468 Doi 10.1371/journal.pone.0049468
81 Nakahara T, Uchi H, Lesokhin AM, Avogadri F, Rizzuto GA, Hirschhorn-Cymerman D, Panageas KS, Merghoub T, Wolchok JD, Houghton AN (2010) Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs. Blood 115: 4384-4392 Doi 10.1182/blood-2009-11-251231
82 Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39: 409-421 Doi 10.1016/s0896-6273(03)00434-3
83 Oddo S, Caccamo A, Tran L, Lambert MP, Glabe CG, Klein WL, LaFerla FM (2006) Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology. J Biol Chem 281: 1599-1604
84 Oddo S, Caccamo A, Tseng B, Cheng D, Vasilevko V, Cribbs DH, LaFerla FM (2008) Blocking Abeta42 accumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: a mechanistic link between Abeta and tau pathology. J Neurosci 28: 12163-12175 Doi 10.1523/JNEUROSCI.2464-08.2008
85 Oddo S, Vasilevko V, Caccamo A, Kitazawa M, Cribbs DH, LaFerla FM (2006) Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles. J Biol Chem 281: 39413-39423 Doi 10.1074/jbc.M608485200
86 Peng S, Garzon DJ, Marchese M, Klein W, Ginsberg SD, Francis BM, Mount HT, Mufson EJ, Salehi A, Fahnestock M (2009) Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease. J Neurosci 29: 9321-9329 Doi 10.1523/JNEUROSCI.4736-08.2009
87 Peng S, Wuu J, Mufson EJ, Fahnestock M (2005) Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J Neurochem 93: 1412-1421 Doi 10.1111/j.1471-4159.2005.03135.x
88 Perez SE, He B, Muhammad N, Oh KJ, Fahnestock M, Ikonomovic MD, Mufson EJ (2011) Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice. Neurobiol Dis 41: 338-352 Doi 10.1016/j.nbd.2010.10.002
89 Petry FR, Pelletier J, Bretteville A, Morin F, Calon F, Hebert SS, Whittington RA, Planel E (2014) Specificity of anti-tau antibodies when analyzing mice models of Alzheimer's disease: problems and solutions. PLoS One 9: e94251 Doi 10.1371/journal.pone.0094251
90 Pietropaolo S, Feldon J, Yee BK (2008) Age-dependent phenotypic characteristics of a triple transgenic mouse model of Alzheimer disease. Behav Neurosci 122: 733-747 Doi 10.1037/a0012520
91 Pietropaolo S, Sun Y, Li R, Brana C, Feldon J, Yee BK (2009) Limited impact of social isolation on Alzheimer-like symptoms in a triple transgenic mouse model. Behav Neurosci 123: 181-195 Doi 10.1037/a0013607
92 Rae EA, Brown RE (2015) The problem of genotype and sex differences in life expectancy in transgenic AD mice. Neurosci Biobehav Rev 57: 238-251 Doi 10.1016/j.neubiorev.2015.09.002
93 Rajamohamedsait H, Rasool S, Rajamohamedsait W, Lin Y, Sigurdsson EM (2017) Prophylactic Active Tau Immunization Leads to Sustained Reduction in Both Tau and Amyloid-β Pathologies in 3xTg Mice. Sci Rep 7: 17034 Doi 10.1038/s41598-017-17313-1
94 Reed-Geaghan EG, Reed QW, Cramer PE, Landreth GE (2010) Deletion of CD14 Attenuates Alzheimer's Disease Pathology by Influencing the Brain's Inflammatory Milieu. The Journal of Neuroscience 30: 15369-15373 Doi 10.1523/jneurosci.2637-10.2010
95 Richardson JTE (2011) Eta squared and partial eta squared as measures of effect size in educational research. Educational Research Review 6: 135-147 Doi 10.1016/j.edurev.2010.12.001
96 Roddick KM, Roberts AD, Schellinck HM, Brown RE (2016) Sex and Genotype Differences in Odor Detection in the 3xTg-AD and 5XFAD Mouse Models of Alzheimer's Disease at 6 Months of Age. Chem Senses 41: 433-440 Doi 10.1093/chemse/bjw018
97 Rosa E, Mahendram S, Ke YD, Ittner LM, Ginsberg SD, Fahnestock M (2016) Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease. Neurobiol Aging 48: 135-142 Doi 10.1016/j.neurobiolaging.2016.08.020
98 Ryabinin AE, Wang YM, Finn DA (1999) Different levels of Fos immunoreactivity after repeated handling and injection stress in two inbred strains of mice. Pharmacol Biochem Behav 63: 143-151 Doi 10.1016/s0091-3057(98)00239-1
99 Sahara N, DeTure M, Ren Y, Ebrahim AS, Kang D, Knight J, Volbracht C, Pedersen JT, Dickson DW, Yen SHet al (2013) Characteristics of TBS-extractable hyperphosphorylated tau species: aggregation intermediates in rTg4510 mouse brain. J Alzheimers Dis 33: 249-263 Doi 10.3233/JAD-2012-121093
100 Sakic B, Cooper MP, Taylor SE, Stojanovic M, Zagorac B, Kapadia M (2015) Behavioral phenotyping of murine disease models with the Integrated Behavioral Station (INBEST). J Vis Exp: Doi 10.3791/51524
101 Sakic B, Denburg JA, Denburg SD, Szechtman H (1996) Blunted sensitivity to sucrose in autoimmune MRL-lpr mice: a curve-shift study. Brain Res Bull 41: 305-311 Doi 10.1016/s0361-9230(96)00190-6
102 Sakic B, Kolb B, Whishaw IQ, Gorny G, Szechtman H, Denburg JA (2000) Immunosuppression prevents neuronal atrophy in lupus-prone mice: evidence for brain damage induced by autoimmune disease? J Neuroimmunol 111: 93-101 Doi 10.1016/s0165-5728(00)00364-7
103 Sakic B, Szechtman H, Denburg SD, Denburg JA (1995) Immunosuppressive treatment prevents behavioral deficit in autoimmune MRL-lpr mice. Physiol Behav 58: 797-802 Doi 10.1016/0031-9384(95)00135-6
104 Sardi F, Fassina L, Venturini L, Inguscio M, Guerriero F, Rolfo E, Ricevuti G (2011) Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly. Autoimmun Rev 11: 149-153
105 Schwartz M, Baruch K (2014) Breaking peripheral immune tolerance to CNS antigens in neurodegenerative diseases: boosting autoimmunity to fight-off chronic neuroinflammation. J Autoimmun 54: 8-14 Doi 10.1016/j.jaut.2014.08.002
106 Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CAet al (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14: 837-842 Doi 10.1038/nm1782
107 Sistigu A, Viaud S, Chaput N, Bracci L, Proietti E, Zitvogel L (2011) Immunomodulatory effects of cyclophosphamide and implementations for vaccine design. Semin Immunopathol 33: 369-383 Doi 10.1007/s00281-011-0245-0
108 Sterniczuk R, Antle MC, Laferla FM, Dyck RH (2010) Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 2. Behavioral and cognitive changes. Brain Res 1348: 149-155 Doi 10.1016/j.brainres.2010.06.011
109 Stevens LM, Brown RE (2015) Reference and working memory deficits in the 3xTg-AD mouse between 2 and 15-months of age: a cross-sectional study. Behav Brain Res 278: 496-505 Doi 10.1016/j.bbr.2014.10.033
110 Stewart C, Campagne O, Davis A, Zhong B, Nair S, Haberman V, Y TP, Janke L, M FR (2019) CNS Penetration of Cyclophosphamide and Metabolites in Mice Bearing Group 3 Medulloblastoma and Non-Tumor Bearing Mice. J Pharm Pharm Sci 22: 612-629 Doi 10.18433/jpps30608
111 Storace D, Cammarata S, Borghi R, Sanguineti R, Giliberto L, Piccini A, Pollero V, Novello C, Caltagirone C, Smith MAet al (2010) Elevation of {beta}-amyloid 1-42 autoantibodies in the blood of amnestic patients with mild cognitive impairment. Arch Neurol 67: 867-872 Doi 10.1001/archneurol.2010.137
112 Stover KR, Campbell MA, Van Winssen CM, Brown RE (2015) Early detection of cognitive deficits in the 3xTg-AD mouse model of Alzheimer's disease. Behav Brain Res 289: 29-38 Doi 10.1016/j.bbr.2015.04.012
113 Strober S, Cheng L, Zeng D, Palathumpat R, Dejbakhsh-Jones S, Huie P, Sibley R (1996) Double negative (CD4-CD8- alpha beta+) T cells which promote tolerance induction and regulate autoimmunity. Immunol Rev 149: 217-230 Doi 10.1111/j.1600-065x.1996.tb00906.x
114 Sy M, Kitazawa M, Medeiros R, Whitman L, Cheng D, Lane TE, Laferla FM (2011) Inflammation induced by infection potentiates tau pathological features in transgenic mice. Am J Pathol 178: 2811-2822 Doi 10.1016/j.ajpath.2011.02.012
115 Thomson CW, Lee BP, Zhang L (2006) Double-negative regulatory T cells: non-conventional regulators. Immunol Res 35: 163-178 Doi 10.1385/IR:35:1:163
116 Torres-Lista V, Gimenez-Llort L (2015) Early postnatal handling and environmental enrichment improve the behavioral responses of 17-month-old 3xTg-AD and non-transgenic mice in the Forced Swim Test in a gender-dependent manner. Behav Processes 120: 120-127 Doi 10.1016/j.beproc.2015.09.011
117 Torres-Lista V, Gimenez-Llort L (2013) Impairment of nesting behaviour in 3xTg-AD mice. Behav Brain Res 247: 153-157 Doi 10.1016/j.bbr.2013.03.021
118 Trinath J, Bayry J (2019) Current trends with FOXP3+ regulatory T cell immunotherapy to contest autoimmunity and inflammation. Immunotherapy 11: 755-758 Doi 10.2217/imt-2019-0069
119 Tseng BP, Green KN, Chan JL, Blurton-Jones M, LaFerla FM (2008) Abeta inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiol Aging 29: 1607-1618 Doi 10.1016/j.neurobiolaging.2007.04.014
120 Ungar L, Altmann A, Greicius MD (2014) Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interaction. Brain imaging and behavior 8: 262-273 Doi 10.1007/s11682-013-9272-x
121 Van der Jeugd A, Parra-Damas A, Baeta-Corral R, Soto-Faguas CM, Ahmed T, LaFerla FM, Gimenez-Llort L, D'Hooge R, Saura CA (2018) Reversal of memory and neuropsychiatric symptoms and reduced tau pathology by selenium in 3xTg-AD mice. Sci Rep 8: 6431 Doi 10.1038/s41598-018-24741-0
122 Wang J, Gu BJ, Masters CL, Wang Y-J (2017) A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain. Nature Reviews Neurology 13: 612-623 Doi 10.1038/nrneurol.2017.111
123 Zovkic IB, Paulukaitis BS, Day JJ, Etikala DM, Sweatt JD (2014) Histone H2A.Z subunit exchange controls consolidation of recent and remote memory. Nature 515: 582-586 Doi 10.1038/nature13707